Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer
2026 · ESMO Open · 0 citations
https://doi.org/10.1016/j.esmoop.2025.106050
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2
Papers
0
Citations
0
h-index
0
i10-index
F. Lynce is an academic researcher from Georgetown University. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Immunotherapy and Biomarkers & Cancer Cells and Metastasis.
Click to start Chat